Auxilium Biotechnologies
PrivateLast Round
VC Round
Dec 11, 2025
Est. Valuation
$92.6M
Total Funding Raised
$7.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Auxilium Biotechnologies is a biotechnology company that develops implantable medical devices and bioprinting solutions for the treatment of traumatic nerve injuries and pioneers space-based biomanufacturing technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Space Technology, Medical Devices, 3D Printing
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Auxilium Biotechnologies Comparables
Compare Auxilium Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Newrotex | 81% | |
| Regenity Biosciences | 78% | |
| Swan NeuroTech | 76% |
Auxilium Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 11, 2025 | ||||
| Grant | Mar 15, 2023 | ||||
| Series A | Jan 17, 2020 |
Auxilium Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Innovation Partnerships | Series A |
| CF Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 108% MoM, from 3.1K to 6.4K.
- Dec 11, 2025
$4M raised in a VC Round.
Auxilium Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Auxilium Biotechnologies's valuation, stock price, and market status.
Is Auxilium Biotechnologies a public or private company?
Auxilium Biotechnologies is a private company.
What is the current stock price of Auxilium Biotechnologies?
Auxilium Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Auxilium Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Auxilium Biotechnologies worth (valuation)?
Auxilium Biotechnologies's valuation is estimated at $92.6M based on funding round data.
Can I buy Auxilium Biotechnologies stock?
Auxilium Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Auxilium Biotechnologies's last funding round?
Auxilium Biotechnologies's most recent funding round was VC Round on December 11, 2025.
Who are the main investors in Auxilium Biotechnologies?
Key investors in Auxilium Biotechnologies include NIH RADx, Innovation Partnerships, CF Ventures.
Will Auxilium Biotechnologies IPO soon?
No public IPO plans have been announced for Auxilium Biotechnologies.
How can I track Auxilium Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Auxilium Biotechnologies's shares on secondary markets.